Metraipolis › archive › dc_9acdf1fffe8a

Synthesis, bioactivity, and molecular docking studies: novel arylpiperazine derivatives as potential new-resistant AR antagonists — Europe PMC PMID:40224223

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40224223
DOI: 10.3389/fchem.2025.1557275
License (as archived): solo-consultazione
Archived: 2026-10-08T00:13:19.600Z
SHA-256 of the archived text: 71932b83058c5345e9279d2d07f4c67382733cf73d7bae1fccdfcbdf109a8ad1
Stable URL of this page: https://metraipolis.com/documento/dc_9acdf1fffe8a

How to cite

Synthesis, bioactivity, and molecular docking studies: novel arylpiperazine derivatives as potential new-resistant AR antagonists — Europe PMC PMID:40224223 — Europe PMC (en), https://europepmc.org/article/MED/40224223 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9acdf1fffe8a (Metraipolis archive dc_9acdf1fffe8a, sha256 71932b83058c5345e9279d2d07f4c67382733cf73d7bae1fccdfcbdf109a8ad1)

BibTeX

@misc{dc9acdf1fffe8a,
  title = {Synthesis, bioactivity, and molecular docking studies: novel arylpiperazine derivatives as potential new-resistant AR antagonists — Europe PMC PMID:40224223},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40224223},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9acdf1fffe8a; sha256 71932b83058c5345e9279d2d07f4c67382733cf73d7bae1fccdfcbdf109a8ad1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40224223. Agents can read the archived copy with the MCP tool read_document.